StockClub

TVTX

TVTXTravere Therapeutics, Inc.$ --
Travere Therapeutics, Inc.

Travere Therapeutics, Inc.

TVTX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
130M USD
YoY +73.4%
Operating Income
-32M USD
YoY +46.6%
Net Income
-22M USD
YoY +63.5%
EPS
-0.24$
YoY +67.1%

Revenue

$490.7M
FY2024 Q1$41.4M
$41.4M
Q1
FY2024 Q2$95.5M
$95.5M
Q2
FY2024 Q3$158.4M
$158.4M
Q3
FY2024 Q4$233.2M
$233.2M
Q4
FY2025 Q1$81.7M
$81.7M
Q1
FY2025 Q2$196.2M
$196.2M
Q2
FY2025 Q3$361M
$361M
Q3
FY2025 Q4$490.7M
$490.7M
Q4
Actual
+$257.6M (+110.5%)

Net Income

$-50.3M
FY2024 Q1$-136.1M
$-136.1M
Q1
FY2024 Q2$-206.5M
$-206.5M
Q2
FY2024 Q3$-261.3M
$-261.3M
Q3
FY2024 Q4$-321.5M
$-321.5M
Q4
FY2025 Q1$-41.2M
$-41.2M
Q1
FY2025 Q2$-54M
$-54M
Q2
FY2025 Q3$-28.3M
$-28.3M
Q3
FY2025 Q4$-50.3M
$-50.3M
Q4
Actual
+$271.3M (+84.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$198.3M
Est:$198.9M
FY2020MISS
$198.3M
FY2021MISS
Actual:$131.8M
Est:$225.7M
FY2021MISS
$131.8M
FY2022MISS
Actual:$109.5M
Est:$208.4M
FY2022MISS
$109.5M
FY2023MISS
Actual:$145.2M
Est:$177.6M
FY2023MISS
$145.2M
FY2024BEAT
Actual:$233.2M
Est:$231M
FY2024BEAT
$233.2M
FY2025MISS
Actual:$490.7M
Est:$499.3M
FY2025MISS
$490.7M

Analyst Estimates